{"nct_id":"NCT05926960","title":"A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2023-06-13","start_date_type":"ACTUAL","primary_completion_date":"2025-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}